Read my last post in a series on data-related misconduct at startup Theranos outlined in the book, “Bad Blood”, where I discuss their lack of administrative barrier between research and clinical data.
The Plan-Do-Study-Act model is promoted for quality assurance/quality improvement in healthcare. But does it have any peer-reviewed evidence base behind it? I examine that in this blog post.
The book “Bad Blood” describes the fall of startup unicorn Theranos, but also provides insight into the company’s abject failure at data stewardship, which I talk about in this blog post.
Learn the “data science of data collection” through my free introductory course! If you want to learn more, continue with the whole six-course series. Great for graduate students and QA/QI professionals!